¡Ø ÇØ´ç ¾ÆÁ¨´Ù´Â °¡¾ÈÀ̹ǷΠ°ÀÇÁ¦¸ñ ¹× ÁÂÀå, ¿¬ÀÚ´Â º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.
½Ã°£ | ÇÁ·Î±×·¥ | ¿¬ÀÚ, ÁÂÀå |
---|---|---|
09:00~09:10 | °³È¸»ç | ÃÖº´¿Á(¼º±Õ°üÀÇ´ë, ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ȸÀå) |
¥°. Updated knowledge in the field of neuromuscular disorders 2022 - 2023 | ÁÂÀå: ±Ç±âÇÑ(ÇѸ²ÀÇ´ë), ¹Ú±â´ö(ÀÌÈÀÇ´ë) | |
09:10~09:35 | Update on neuromuscular junction disorder | ½ÅÇÏ¿µ(¿¬¼¼ÀÇ´ë) |
09:35~10:00 | Update on motor neuron disease | ÃÖ¼®Áø(¼¿ïÀÇ´ë) |
10:00~10:25 | Update on spinal mucular atrophy | ÀÌÁ¾¸ñ(°æºÏÀÇ´ë) |
10:25~10:35 | Q & A | |
10:35~10:45 | Intermission | |
¥±. Plenary Lecture | ÁÂÀå: ÃÖº´¿Á(¼º±Õ°üÀÇ´ë) | |
10:45~11:35 | Inflammatory neuropathies (¾È) | Yusuf A. Rajabally(Aston University) |
11:35~11:45 | Q & A | |
11:45~11:50 | Intermission | |
11:50~12:30 | Àӽà ÃÑȸ & Lunch | |
¥². Autoantibodies : great compass toward novel discovery of neuromuscular disorder | ÁÂÀå: ±è´ë¼º(ºÎ»êÀÇ´ë), ÃÖ¿µÃ¶(¿¬¼¼ÀÇ´ë) | |
12:30~12:50 | Positioning of myositis-related antibody testing in diagnostic work-up | ¹ÚÇüÁØ(¿¬¼¼ÀÇ´ë) |
12:50~13:10 | Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome | ÀÌ»ó°ï(Áß¾ÓÀÇ´ë) |
13:10~13:30 | Autoantibodies Associated with Paraneoplastic Neuropathies - growing spectrum | ±èÇöÁø(¿ï»êÀÇ´ë) |
13:30~13:40 | Q & A | |
13:40~13:50 | Intermission | |
¥³. Scientific Session | ÁÂÀå: ±è½ÂÇö(ÇѾçÀÇ´ë), ±èº´Á¶(°í·ÁÀÇ´ë) | |
13:50~14:05 | 1st (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
14:05~14:20 | 2nd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
14:20~14:35 | 3rd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
14:35~14:50 | 4th (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
¥´. Poster Session | ÁÂÀå: ¼ÕÀºÈñ(Ãæ³²ÀÇ´ë), Á¶Áß¾ç(ÀÎÁ¦ÀÇ´ë) | |
14:50~15:20 | Poster Session | |
¥µ. Research Highlight Track | ÁÂÀå: ±èº´ÁØ(¼º±Õ°üÀÇ´ë), ±Ç¿ÀÇö(À»ÁöÀÇ´ë) | |
15:20~15:35 | 1st (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
15:35~15:50 | 2nd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
15:50~16:05 | 3rd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®) | |
16:05~ | ÄûÁî Ãß÷ ¹× Æóȸ»ç |